Clinical trial
Innovative Therapy to Treat Women With Angina With Nonobstructive Coronary Artery Disease (ANOCA) and Coronary Microvascular Disease
NCT06600178 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Innovative Therapy to Treat Women With Angina With Nonobstructive Coronary Artery Disease (ANOCA) and Coronary Microvascular Disease
- Lead sponsor
- University of Virginia
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- July 15, 2025
- Completion date
- June 29, 2029
- Enrollment
- 150 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
angina patients with non-obstructive coronary artery disease, coronary microvascular disease, coronary microvascular dysfunction (cmd)